pharma-company /Medicinal products /Active ingredients

Rx · PZN 04897458, 04897493, 04897524

TILICOMP beta 50-4 mg prolonged-release tablets

German trade nameTILICOMP beta 50-4 mg Retardtabletten

Active ingredientTilidine and naloxoneSubstance (DE)Tilidin und NaloxonPharmaceutical formProlonged-release tablets

According to the data available to us: no longer marketed

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Extended ambient max. 30 °C

Average purchase price (B2B)

~ €13

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for TILICOMP beta 50-4 mg prolonged-release tablets.

Review purchasing terms

TILICOMP beta 50-4 mg prolonged-release tablets contains the active ingredient Tilidine and naloxone (German Tilidin und Naloxon) and comes as Prolonged-release tablets. 3 pack sizes of this product are recorded. All packs reach a pharma availability index of 0.0 out of 10 over the past 30 days. According to our records, none of the recorded packs is currently marketed on a regular basis – sources of supply can be checked on request.


Pack sizes · 3 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
048974580.00.0~ €5
048974930.00.0~ €12
048975240.00.0~ €23

According to the data available to us, TILICOMP beta 50-4 mg prolonged-release tablets is no longer regularly marketed. We help you identify successor products, remaining stock and import routes.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across all 3 recorded PZNs.